Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 19/1/19961 min de lectura
Design of Experimental Studies of Transmission of Creutzfeldt- Jakob Disease (CJD) by Plasma and Plasma Derivatives; Notice of Public Workshop
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), is announcing a public workshop on design of experimental studies to investigate possible transmission of Creutzfeldt-Jakob Disease (CJD) by plasma and plasma derivatives. This scientific workshop, sponsored by FDA and the National Heart, Lung, and Blood Institute, is intended to foster an indepth discussion of the available laboratory methods which would underlie experimental studies on the transmission of CJD and related diseases by plasma and derived products.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →